How active is Private Equity / PE-Backed Roll-Up in medical practice specialty acquisitions?

19 disclosed private equity / pe-backed roll-up acquisitions of medical practice specialty businesses analyzed (19 from 2018+). Run the ExitValue.ai calculator to see what this buyer pool would pay for your specific business.

Who are the most active private equity / pe-backed roll-up buyers of medical practice specialty businesses?

Top recent acquirers by deal count: Audax Private Equity (2 deals), Partners Group (2 deals), The Carlyle Group (1 deals), Kohlberg & Company (1 deals), Apollo Global Management (1 deals), Ares Management (1 deals).

BUYER POOL ANALYSIS

Selling a Medical Practice Specialty to Private Equity / PE-Backed Roll-Up buyers

Private equity firms and PE-backed platform consolidators acquiring for roll-up, add-on, or platform plays. Pricing tends to lead the market for fee-viable scale, with multi-bidder competitive processes above the EBITDA floor.

Quick answers

How many disclosed transactions?: 19 deals total (19 from 2018+), filtered to Private Equity / PE-Backed Roll-Up acquirers of medical practice specialty businesses.
Most active buyers: Audax Private Equity (2) · Partners Group (2) · The Carlyle Group (1) · Kohlberg & Company (1) · Apollo Global Management (1) · Ares Management (1)
What would this buyer pool pay for my business?: Run the ExitValue.ai calculator to see your medical practice specialty priced against the 19 disclosed private equity / pe-backed roll-up transactions in this segment. The engine surfaces the specific multiples that apply to your size, margin, and growth profile.

Recent disclosed deals

Private Equity / PE-Backed Roll-Up acquisitions of medical practice specialty businesses with named target and named acquirer.

Year	Target	Acquirer
2024	United Urology Group	Audax Private Equity
2024	Vantive (Baxter Kidney Care Segment)	The Carlyle Group
2023	United Digestive	Kohlberg & Company
2022	Forefront Dermatology	Partners Group
2022	GI Alliance	Apollo Global Management
2022	Pima Heart & Vascular	Ares Management

What this buyer pool prices for

Private equity acquirers price for scale and roll-up arbitrage. They pay up for businesses that fit a platform thesis - recurring revenue mix above 30%, technician/professional depth, clean financials, and a management layer that survives integration. A medical practice specialty that fits the platform thesis prices materially above what an individual buyer would pay because PE is buying a platform piece, not an owner-operated shop.

Methodology note

Deal flow shown reflects disclosed M&A transactions in the ExitValue.ai database, filtered to medical practice specialty businesses acquired by private equity / pe-backed roll-up buyers. Deal counts shown reflect deals with disclosed financials only - total transaction count for this buyer pool is typically 2-3x larger. The valuation engine reveals the specific multiples that apply to your business when you run the calculator above. Full methodology

What's your medical practice specialty worth to private equity / pe-backed roll-up?

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

✓Sellability score with 5-driver breakdown and lift estimates
✓Named comparable M&A transactions in your sub-vertical
✓AI-written analysis grounded in your specific inputs

Run my valuation analysis →

Engine-grounded estimate. Comparable private equity / pe-backed roll-up deals on the full results page.